Nov 19, 2026
Alfa Cytology focuses on radionuclide labeling, compound analysis, and preclinical studies, covering multiple stages of radiopharmaceutical development.
New York, United States, November 19, 2026 /MarketersMEDIA/ -- Radiolabeling is an important technical link in the development of radiopharmaceuticals and can be used for compound tracking, diagnostic imaging, and related pharmacological studies. However, completing the labeling is only part of the research process. Researchers also need to investigate the properties, stability, and biological behavior of the labeled compounds according to the project objectives to provide a basis for subsequent experiments. Alfa Cytology provides radiolabeling and related research services, including compound preparation, analysis, and preclinical studies.
The preparation of radiolabeled compounds involves the selection of labeling sites, optimization of synthesis routes, purification, and analysis of products. Specific plans need to be determined in combination with the characteristics of the compounds and the research purpose, and further research could also involve stability, pharmacokinetics, and biodistribution. Therefore, the research process not only needs to consider how to prepare the labeled compounds, but also needs to determine the corresponding analysis and evaluation methods according to the intended use.
After the preparation of the compounds, analytical studies help to further understand their properties and performance during the experiment. Alfa Cytology provides pharmacokinetic and pharmacodynamic (PK/PD) studies, biodistribution and dosimetry studies, and stability and shelf-life studies of radiolabeled compounds. Analytical methods also include high-performance liquid chromatography (HPLC), liquid chromatography-tandem mass spectrometry (LC-MS/MS), and gamma counting. Depending on the research objectives of different projects, these methods can be used to investigate the relevant characteristics of compounds and provide an experimental basis for subsequent pharmacological research and preclinical evaluation.
Radiolabeling protocols also need to be selected according to the intended research application. Alfa Cytology's services include radiolabeling for PET, SPECT, and other studies, as well as the labeling of small molecules, biomolecules, and related conjugates. These techniques can be used in molecular imaging, drug research, and studies related to targeted radiotherapy. The appropriate approach depends on the properties of the compounds and the objectives of the project.
In addition to radiolabeling services, Alfa Cytology also provides research and development services related to radionuclide-drug conjugates (RDCs). RDC research and development involves components such as radionuclides, chelators, linkers, and targeting molecules, and needs to be designed and evaluated in combination with different coupling types and research phases. The services listed on the official website include RDC design, payload development, linker design and synthesis, chelator screening and synthesis, coupling, characterization, and preclinical research, covering different types of radionuclide coupling schemes such as antibodies, peptides, small molecules, and siRNA.
Radiolabeling and RDC-related studies can be applied to diagnostic imaging, targeted radiotherapy, and drug discovery. The evaluation focus of different projects depends on the candidate compounds and their research objectives, and may involve aspects such as compound stability, biodistribution, pharmacokinetics, or dosimetry. Combining compound preparation with subsequent analysis and preclinical studies helps researchers structure experiments around specific R&D questions, rather than just completing the labeling as an endpoint.
About Alfa Cytology
Alfa Cytology focuses on cancer research and related R&D services, covering drug discovery, radiopharmaceutical research, and preclinical research. The company provides technical services across different stages of research and development, including radiolabeling, radionuclide-drug conjugate (RDC) development, and compound analysis, for research areas such as diagnostic imaging, targeted radiotherapy, and drug development.
Contact Info:
Name: Toya Davis
Email: Send Email
Organization: Alfa Cytology
Website: https://www.rdcthera.com
Release ID: 89210124
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
MANILA, Philippines—The Department of Justice (DOJ) confirmed that Muntinlupa prosecutors dismissed the complaints of malicious mischief, alarms and scandals against all 233 individuals arrested during a protest march ahead of the Asean Summit. As a result, the prosecutors ordered the release of the demonstrators. In a statement issued Wednesday evening, DOJ spokesperson Atty. Polo Martinez
MANILA, Philippines — Vice President Sara Duterte’s lawyers have been warned about presenting video clips of former Chief Justice Renato Corona testifying during his own impeachment trial, with at least two senator-judges noting that the former Supreme Court head was convicted despite his grievances. During Duterte’s impeachment trial on Thursday, defense counsel Mark Vinluan presented clips
MANILA, Philippines — Another representative of the Center for International Trade Expositions and Missions (CITEM) will testify on Friday in the impeachment trial of Vice President Sara Duterte after a department manager requested the postponement of her appearance. The court ordered this on Day 44 of Duterte’s trial, after Rowena Mendoza, CITEM Department Manager III,
MANILA, Philippines — Presiding officer Sen. Francis “Chiz” Escudero told the Senate impeachment clerk of court to remove and edit the “inappropriate” fire transition effects from the records that appeared while Sen. Alan Peter Cayetano was leading the opening prayer for the trial. The fiery effects, photos and video clips of which have since gone viral,
Senator-judges cast doubt on the capability of a defense witness to answer questions about a report detailing Duterte"s alleged unexplained wealth, especially since he didn't read it.
Court orders reparations, refugee returns, and accountability for atrocities.
President Ferdinand “Bongbong” Marcos Jr. and First Lady Liza Araneta Marcos walked into the venue of the APEC gala dinner in Shenzhen on Wednesday night with the orchestra playing an instrumental version of Freddie Aguilar's "Anak," according to Ivan Mayrina's report on "24 Oras."
MANILA, Philippines — Environmental and toxics watchdog EcoWaste Coalition has detected mercury levels above Asean’s limit for cosmetics in six more Pakistan-made skin-lightening creams sold online. In a statement Thursday, the group said Biocos Belle Visage Vitamin C Whitening Cream registered the highest reading at 48,920 parts per million (ppm), nearly 49,000 times the 1-ppm
Party General Secretary and President To Lam called on the U.S. to support Vietnam in successfully hosting APEC 2027 when he met President Donald Trump on the sidelines of the APEC 2026 Economic Leaders' Week in Shenzhen, China, on Thursday.
With the conclusion of the 44th day of Vice President Sara Duterte"s impeachment trial, the House prosecution said that her defense team has yet to debunk the evidence against her.
MANILA, Philippines — Anti-Money Laundering Council (AMLC) documents concerning Vice President Sara Duterte and her husband presented during the House committee on justice impeachment proceedings are “confidential,” a defense witness testified before the Senate impeachment court on Thursday. On the 44th day of the trial, defense counsel Mark Vinluan examined lawyer and accountant Reinel dela
He says authorities need more time, but decisive action cannot wait.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.